Filing Details
- Accession Number:
- 0001209191-17-025255
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-04-04 18:35:24
- Reporting Period:
- 2017-03-31
- Filing Date:
- 2017-04-04
- Accepted Time:
- 2017-04-04 18:35:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
931336 | Dean Foods Co | DF | Dairy Products (2020) | 752559681 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1464801 | Wayne J Mailloux | C/O Dean Foods Company 2711 North Haskell Avenue, Suite 3400 Dallas TX 75204 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-03-31 | 2,310 | $0.00 | 104,450 | No | 4 | A | Direct | |
Common Stock | Disposition | 2017-04-03 | 3,033 | $19.70 | 101,417 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Footnotes
- These are shares of restricted stock issued in lieu of payment of the cash compensation owed to the Reporting Person for services as a non-employee director. These restricted shares vest in three equal increments, with the first vesting occurring as of the date the shares were issued and then annually thereafter. Voting and dividend rights attach immediately on the entire number of shares issued.
- Sale is pursuant to a 10b5-1 trading plan dated February 27, 2017, between the Reporting Person and UBS Financial Services Inc., acting as agent, to permit the orderly disposition of a portion of the Reporting Person's holdings of the Issuer's common stock, par value $0.01 per share.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.51 to $19.86, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.